Fingerprint
Dive into the research topics of 'The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo
Petra Heffeter, Bihter Atil, Kushtrim Kryeziu, Diana Groza, Gunda Koellensperger, Wilfried Körner, Ute Jungwirth, Thomas Mohr, Bernhard K Keppler, Walter Berger
Research output: Contribution to journal › Article › peer-review
78
Citations
(SciVal)